prostate cancer
Item
clinical indicators consistent with the community standards of medical care that would justify a biopsy of the prostate for the diagnosis of cancer, including ≥ 1 of the following:
boolean
C0600139 (UMLS CUI [1])
elevated PSA level
Item
psa level above the absolute value of 4 ng/ml or above a published age-ethnic adjusted psa level appropriate for the community
boolean
C0138741 (UMLS CUI [1,1])
C3163633 (UMLS CUI [1,2])
significant psa velocity
Item
rising psa that should represent a clinically significant psa velocity (e.g., an estimated annual change in the psa velocity ≥ 0.75 ng/ml)
boolean
C1518823 (UMLS CUI [1])
clinically significant change in the prostate
Item
abnormal digital rectal examination of the prostate that identifies a clinically significant change in the prostate (e.g., a prostate nodule or a change in the firmness of the prostate)
boolean
C1096657 (UMLS CUI [1])
prostate biopsy
Item
documentation of the clinical assessment that justified the prostate biopsy that allows classification of the patient to high-risk groups
boolean
C0194804 (UMLS CUI [1])
prostate biopsy negative
Item
prostate biopsy negative for cancer within the past 12 months
boolean
C0194804 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
negative for high-grade prostatic intraepithelial neoplasia
Item
prostate biopsy negative for high-grade prostatic intraepithelial neoplasia (pin)
boolean
C0194804 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
C1168327 (UMLS CUI [1,3])
PIN grade 1
Item
pin allowed provided it is grade 1
boolean
C0282612 (UMLS CUI [1,1])
C0687695 (UMLS CUI [1,2])
creatinine
Item
creatinine < 2 times upper limit of normal (uln)
boolean
C0010294 (UMLS CUI [1])
bilirubin
Item
bilirubin < 2 times uln
boolean
C0005437 (UMLS CUI [1])
sgot and sgpt
Item
sgot and sgpt < 2 times uln
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
alkaline phosphatase
Item
alkaline phosphatase < 2 times uln
boolean
C0201850 (UMLS CUI [1])
history of malignancy
Item
no history of a prior malignancy except for the following:
boolean
C0006826 (UMLS CUI [1])
basal cell or squamous cell carcinoma
Item
adequately treated basal cell or squamous cell carcinoma
boolean
C0007117 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0007137 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
complete remission
Item
adequately treated (i.e., complete surgical removal with negative margins) stage i cancer from which the patient is currently in complete remission
boolean
C0677874 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
other cancer
Item
any other cancer from which the patient has been disease-free for 5 years
boolean
C1707251 (UMLS CUI [1,1])
C0242793 (UMLS CUI [1,2])
chemotherapy or radiotherapy
Item
no prior systemic chemotherapy or radiotherapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
concurrent selenium
Item
at least 90 days since prior and no other concurrent selenium > 55 μg/day as a dietary supplement (including multivitamin supplements)
boolean
C0521939 (UMLS CUI [1])
concurrent participation in any other clinical trial
Item
more than 30 days since prior and no concurrent participation in any other clinical trial involving a medical, surgical, nutritional, or life-style intervention (e.g., dietary modifications, exercise)
boolean
C2348568 (UMLS CUI [1])